U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Familial type 3 hyperlipoproteinemia

MedGen UID:
9364
Concept ID:
C0020479
Disease or Syndrome
Synonyms: Apolipoprotein e, deficiency or defect of; Broad beta disease; Broad-betalipoproteinemia; Dysbetalipoproteinemia; Dysbetalipoproteinemia due to defect in apolipoprotein e-d; Familial dysbetalipoproteinemia; Familial hyperbeta- and prebetalipoproteinemia; Familial hypercholesterolemia with hyperlipemia; Floating-betalipoproteinemia; Hyperlipemia with familial hypercholesterolemic xanthomatosis; Hyperlipoproteinemia type 3; Hyperlipoproteinemia type III; Remnant removal disease
SNOMED CT: Familial type 3 hyperlipoproteinemia (398796005); Familial hyperbetalipoproteinemia and hyperprebetalipoproteinemia (398796005); Remnant hyperlipidemia (398796005); Remnant hyperlipoproteinemia (398796005); Dysbetalipoproteinemia (398796005); Primary dysbetalipoproteinemia (398796005); Carbohydrate induced hyperlipemia (398796005); Fredrickson type III hyperlipoproteinemia (398796005); Familial hypercholesterolemia with hyperlipemia (398796005); Floating beta disease (398796005); Broad beta disease (398796005); Apolipoprotein E deficiency (398796005)
Modes of inheritance:
Autosomal dominant inheritance
MedGen UID:
141047
Concept ID:
C0443147
Intellectual Product
Source: Orphanet
A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in heterozygotes. In the context of medical genetics, an autosomal dominant disorder is caused when a single copy of the mutant allele is present. Males and females are affected equally, and can both transmit the disorder with a risk of 50% for each child of inheriting the mutant allele.
Non-Mendelian inheritance
MedGen UID:
109109
Concept ID:
C0600599
Genetic Function
Source: Orphanet
A mode of inheritance that depends on genetic determinants in more than one gene.
 
Gene (location): APOE (19q13.32)
 
Monarch Initiative: MONDO:0018473
OMIM®: 617347
Orphanet: ORPHA412

Definition

Hyperlipoproteinemia type III, also called dysbetalipoproteinemia, is characterized by hyperlipidemia due to accumulation of remnants of the triglyceride (TG)-rich lipoproteins (TGRL), very low density lipoproteins (VLDL), and chylomicrons (CM), in response to dysfunctional genetic variants of apolipoprotein E or absence of apoE (summary by Blum, 2016). [from OMIM]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
Follow this link to review classifications for Familial type 3 hyperlipoproteinemia in Orphanet.

Professional guidelines

PubMed

Navarro Hermoso A, Valdivielso P
Clin Investig Arterioscler 2021 May;33 Suppl 2:75-79. doi: 10.1016/j.arteri.2021.01.004. PMID: 34006359
Gallo A, Béliard S, D'Erasmo L, Bruckert E
Curr Atheroscler Rep 2020 Aug 27;22(11):63. doi: 10.1007/s11883-020-00885-1. PMID: 32852651
Brown WV, Goldberg I, Duell B, Gaudet D
J Clin Lipidol 2018 Mar-Apr;12(2):254-263. Epub 2018 Mar 5 doi: 10.1016/j.jacl.2018.02.018. PMID: 29534878

Recent clinical studies

Etiology

Schneider WJ, Kovanen PT, Brown MS, Goldstein JL, Utermann G, Weber W, Havel RJ, Kotite L, Kane JP, Innerarity TL, Mahley RW
J Clin Invest 1981 Oct;68(4):1075-85. doi: 10.1172/jci110330. PMID: 6270194Free PMC Article

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...